Skip to main content
Top
Gepubliceerd in: Journal of Behavioral Medicine 3/2008

01-06-2008

The impact of medication regimen factors on adherence to chronic treatment: a review of literature

Auteurs: Karen S. Ingersoll, Jessye Cohen

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 3/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

This article reviews recent literature in chronic illness or long-term health management including asthma, contraception, diabetes, HIV disease, and hypertension/cardiovascular disease, mental disorders, pain, and other diseases to determine the relationship between regimen factors and adherence to medications. The authors conducted an electronic literature search to detect articles published between 1998 and 2007. Articles were included if they pertained to a chronic illness or to contraception, included a clear definition of how adherence was measured, and included regimen factors as primary or secondary explanatory variables. Methodology of the studies varied greatly, as did methods of measuring adherence and regimen factors. Surprisingly few of these articles concerned (1) chronic treatment, (2) regimen factors such as dosing, pill burden, and regimen complexity, and (3) adherence measured in a clear manner. Most studies failed to use state-of-the-art methods of measuring adherence. Despite these flaws, a suggestive pattern of the importance of regimen factors, specifically dose frequency and regimen complexity, emerged from this review.
Literatuur
go back to reference Amico, K. R., Harman, J. J., & Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndrome, 41(3), 285–297.CrossRef Amico, K. R., Harman, J. J., & Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndrome, 41(3), 285–297.CrossRef
go back to reference Ammassari, A. A., Starace, F., Aloisi, M. S., Trotta, M. P., Murri, R., D’Arminio Monforte, A., & Antinori, A. (2003). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 61, 723–724.PubMed Ammassari, A. A., Starace, F., Aloisi, M. S., Trotta, M. P., Murri, R., D’Arminio Monforte, A., & Antinori, A. (2003). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 61, 723–724.PubMed
go back to reference Balint, S., & O’Donnell, R. (2007). Beyond compliance. Occupational Health & Safety (Waco, Tex.), 76(6), 104, 106–107. Balint, S., & O’Donnell, R. (2007). Beyond compliance. Occupational Health & Safety (Waco, Tex.), 76(6), 104, 106–107.
go back to reference Bedell, S. E., Jabbout, S., Goldberg, R., Glaser, H., Gobble, S., & Young-Xu, Y., et al. (2000). Discrepancies in the use of medications: Their extent and predictors in an outpatient practice. Archives of Internal Medicine, 160, 2129–2134.PubMedCrossRef Bedell, S. E., Jabbout, S., Goldberg, R., Glaser, H., Gobble, S., & Young-Xu, Y., et al. (2000). Discrepancies in the use of medications: Their extent and predictors in an outpatient practice. Archives of Internal Medicine, 160, 2129–2134.PubMedCrossRef
go back to reference Burke, W. J., & McArthur-Miller, D. A. (2001). Exploring treatment alternatives: Weekly dosing of fluoxetine for the continuation phase of major depressive disorder. Journal of Clinical Psychiatry, 62(Suppl), 38–42.PubMed Burke, W. J., & McArthur-Miller, D. A. (2001). Exploring treatment alternatives: Weekly dosing of fluoxetine for the continuation phase of major depressive disorder. Journal of Clinical Psychiatry, 62(Suppl), 38–42.PubMed
go back to reference Burkman, R. T. (2002). The transdermal contraceptive patch: A new approach to hormonal contraception. International Journal of Fertility Womens’ Medicine, 47, 69–76. Burkman, R. T. (2002). The transdermal contraceptive patch: A new approach to hormonal contraception. International Journal of Fertility Womens’ Medicine, 47, 69–76.
go back to reference Chapman, R. H., Benner, J. S., Petrilla, A. A., Tierce, J. C., Collins, S. R., Battleman, D. S., et al. (2005). Predictors of adherence with antihypertensive and lipid-lowering therapy. Archives of Internal Medicine, 165, 1147–1152.PubMedCrossRef Chapman, R. H., Benner, J. S., Petrilla, A. A., Tierce, J. C., Collins, S. R., Battleman, D. S., et al. (2005). Predictors of adherence with antihypertensive and lipid-lowering therapy. Archives of Internal Medicine, 165, 1147–1152.PubMedCrossRef
go back to reference Chengappa, K. N., Parepally, H., Brar, J. S., Mullen, J., Shilling, A., & Goldstein, J. M. (2003). A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: A pilot study. Canadian Journal of Psychiatry, 48, 187–194. Chengappa, K. N., Parepally, H., Brar, J. S., Mullen, J., Shilling, A., & Goldstein, J. M. (2003). A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: A pilot study. Canadian Journal of Psychiatry, 48, 187–194.
go back to reference Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapy, 23, 1296–1310.CrossRef Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapy, 23, 1296–1310.CrossRef
go back to reference Dezii, C. M., Kawabata, H., & Tran, M. (2002). Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. Southern Medical Journal, 95, 68–71.PubMed Dezii, C. M., Kawabata, H., & Tran, M. (2002). Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. Southern Medical Journal, 95, 68–71.PubMed
go back to reference Dieben, T. O., Roumen, F. J., & Apter, D. (2002). Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstetrics and Gynecology, 100, 585–593.PubMedCrossRef Dieben, T. O., Roumen, F. J., & Apter, D. (2002). Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstetrics and Gynecology, 100, 585–593.PubMedCrossRef
go back to reference Dittrich, R., Parker, L., Rosen, J. B., Shangold, G., Creasy, G. W., Fisher, A. C., & Ortho Evra/Evra 001 Study Group (2002). Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. American Journal of Obstetrics and Gynecology, 186, 15–20. Dittrich, R., Parker, L., Rosen, J. B., Shangold, G., Creasy, G. W., Fisher, A. C., & Ortho Evra/Evra 001 Study Group (2002). Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. American Journal of Obstetrics and Gynecology, 186, 15–20.
go back to reference Dolce, J. J., Crisp, C., Manzella, B., Richards, J. M., Hardin, J. M., & Bailey, W. C. (1991). Medication adherence patterns in chronic obstructive pulmonary disease. Chest, 99, 837–841.PubMedCrossRef Dolce, J. J., Crisp, C., Manzella, B., Richards, J. M., Hardin, J. M., & Bailey, W. C. (1991). Medication adherence patterns in chronic obstructive pulmonary disease. Chest, 99, 837–841.PubMedCrossRef
go back to reference Donnan, P. T., MacDonald, T. M., & Morris, A. D. (1996). Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: A retrospective cohort study. Diabetic Medicine, 19, 270–284. Donnan, P. T., MacDonald, T. M., & Morris, A. D. (1996). Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: A retrospective cohort study. Diabetic Medicine, 19, 270–284.
go back to reference Dunbar-Jacob J., Bohachick P., Mortimer M. K., Sereika S. M., & Foley S. M. (2003). Medication adherence in persons with cardiovascular disease. Journal of Cardiovascular Nursing, 18, 209–218.PubMed Dunbar-Jacob J., Bohachick P., Mortimer M. K., Sereika S. M., & Foley S. M. (2003). Medication adherence in persons with cardiovascular disease. Journal of Cardiovascular Nursing, 18, 209–218.PubMed
go back to reference Eisen, S. A., Miller, D. K., & Woodward, R. S. (1990). The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine, 150, 1881–1884.PubMedCrossRef Eisen, S. A., Miller, D. K., & Woodward, R. S. (1990). The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine, 150, 1881–1884.PubMedCrossRef
go back to reference Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome, 18, 117–125. Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome, 18, 117–125.
go back to reference Eron, J. J., Yetzer, E. S., Ruane, P. J., et al. (2000). Efficacy, safety, and adherence with a twice daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS, 14, 671–681.PubMedCrossRef Eron, J. J., Yetzer, E. S., Ruane, P. J., et al. (2000). Efficacy, safety, and adherence with a twice daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS, 14, 671–681.PubMedCrossRef
go back to reference Ferguson, T. F., Stewart, K. E., Funkhouser, E., Tolson, J., Westfall, A. O., & Saag, M. S. (2002). Patient-perceived barriers to antiretroviral adherence: Associations with race. AIDS Care, 14, 607–617.PubMedCrossRef Ferguson, T. F., Stewart, K. E., Funkhouser, E., Tolson, J., Westfall, A. O., & Saag, M. S. (2002). Patient-perceived barriers to antiretroviral adherence: Associations with race. AIDS Care, 14, 607–617.PubMedCrossRef
go back to reference Flandre, P., Peytavin, G., Meiffredy, V., Saidi, Y., Descomps, D., Delagnes, M., Brun-Vezinet, F., & Roffi, F. (2002). Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antiviral Therapy, 7, 113–121.PubMed Flandre, P., Peytavin, G., Meiffredy, V., Saidi, Y., Descomps, D., Delagnes, M., Brun-Vezinet, F., & Roffi, F. (2002). Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antiviral Therapy, 7, 113–121.PubMed
go back to reference Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46, 93–108.PubMedCrossRef Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46, 93–108.PubMedCrossRef
go back to reference Gallo, M. F., Grimes, D. A., & Schulz, K. F. (2003). Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews, 1, CD003552. Gallo, M. F., Grimes, D. A., & Schulz, K. F. (2003). Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews, 1, CD003552.
go back to reference George, J., Phun, Y. T., Bailey, M. J., Kong, D. C., & Stewart, K. (2004). Development and validation of the medication regimen complexity index. The Annals of Pharmacotherapy, 38, 1369–1376.PubMedCrossRef George, J., Phun, Y. T., Bailey, M. J., Kong, D. C., & Stewart, K. (2004). Development and validation of the medication regimen complexity index. The Annals of Pharmacotherapy, 38, 1369–1376.PubMedCrossRef
go back to reference George, J., & Shalansky, S. J. (2007). Predictors of refill non-adherence in patients with heart failure. British Journal of Clinical Pharmacology, 63, 488–493.PubMedCrossRef George, J., & Shalansky, S. J. (2007). Predictors of refill non-adherence in patients with heart failure. British Journal of Clinical Pharmacology, 63, 488–493.PubMedCrossRef
go back to reference Gerald, L. B., McClure, L. A., Harrington, K. F., Mangan, J. M., Gibson, L., Atchison, J., et al. (2007). Design of the supervised asthma therapy study: Implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials, in press. Gerald, L. B., McClure, L. A., Harrington, K. F., Mangan, J. M., Gibson, L., Atchison, J., et al. (2007). Design of the supervised asthma therapy study: Implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials, in press.
go back to reference Golden, R. N., Nemeroff, C. B., McSorley, P., et al. (2002). Efficacy and tolerability of controlled-release and immediate release paroxetine in the treatment of depression. Journal of Clinical Psychiatry, 63, 577–584.PubMed Golden, R. N., Nemeroff, C. B., McSorley, P., et al. (2002). Efficacy and tolerability of controlled-release and immediate release paroxetine in the treatment of depression. Journal of Clinical Psychiatry, 63, 577–584.PubMed
go back to reference Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Kaplan, A. H., & Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756–765.PubMedCrossRef Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Kaplan, A. H., & Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756–765.PubMedCrossRef
go back to reference Grant, R. W., Devita, N. G, Singer, D. E., & Meigs, J. B. (2003). Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care, 26, 1408–1412.PubMedCrossRef Grant, R. W., Devita, N. G, Singer, D. E., & Meigs, J. B. (2003). Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care, 26, 1408–1412.PubMedCrossRef
go back to reference Halkitis, P. N., Parsons, J. T., Wolitski, R. J., & Remien, R. H. (2003). Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care, 15, 89–102.PubMedCrossRef Halkitis, P. N., Parsons, J. T., Wolitski, R. J., & Remien, R. H. (2003). Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care, 15, 89–102.PubMedCrossRef
go back to reference Hanchak, N. A., Patel, M. B., Berlin, J. A., & Strom, B. L. (1996). Patient misunderstanding of dosing instructions. Journal General Internal Medicine, 11, 325–328.CrossRef Hanchak, N. A., Patel, M. B., Berlin, J. A., & Strom, B. L. (1996). Patient misunderstanding of dosing instructions. Journal General Internal Medicine, 11, 325–328.CrossRef
go back to reference Hays, H., Hagen, N., Thirlwell, M., Dhaliwal, H., Babul, N., Harsanyi, Z., & Darke, A. C. (1994). Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer, 74, 1808–1816.PubMedCrossRef Hays, H., Hagen, N., Thirlwell, M., Dhaliwal, H., Babul, N., Harsanyi, Z., & Darke, A. C. (1994). Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer, 74, 1808–1816.PubMedCrossRef
go back to reference Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow prescribed treatment: Clinical applications. Journal of the American Medical Association, 288, 2880–2883.PubMedCrossRef Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow prescribed treatment: Clinical applications. Journal of the American Medical Association, 288, 2880–2883.PubMedCrossRef
go back to reference Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950.
go back to reference Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50, 385–391.PubMedCrossRef Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50, 385–391.PubMedCrossRef
go back to reference Iskedjian, M., Einarson, T. R., MacKeigan, L. D., Shear, N., Addis, A., Mittmann, N., & Ilersich, A. L. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis. Clinical Therapy, 24, 302–316.CrossRef Iskedjian, M., Einarson, T. R., MacKeigan, L. D., Shear, N., Addis, A., Mittmann, N., & Ilersich, A. L. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis. Clinical Therapy, 24, 302–316.CrossRef
go back to reference Kane, S. V. (2006). Systematic review: Adherence issues in the treatment of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 23, 577–585.PubMedCrossRef Kane, S. V. (2006). Systematic review: Adherence issues in the treatment of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 23, 577–585.PubMedCrossRef
go back to reference Kardas, P. (2005). The DIACOM study (effect of Dosing frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes, Obesity and Metabolism, 7, 722–728.PubMedCrossRef Kardas, P. (2005). The DIACOM study (effect of Dosing frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes, Obesity and Metabolism, 7, 722–728.PubMedCrossRef
go back to reference Katlama, C., Clumeck, N., Fenske, S., et al. (2001). Use of trizivir to simplify therapy in HAART-experienced patients with long-term suppression of HIV-RNA: TRIZIAL study (AZL 30002) 24-week results. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Feb. 4–8, 2001, Abstract 316. Katlama, C., Clumeck, N., Fenske, S., et al. (2001). Use of trizivir to simplify therapy in HAART-experienced patients with long-term suppression of HIV-RNA: TRIZIAL study (AZL 30002) 24-week results. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Feb. 4–8, 2001, Abstract 316.
go back to reference Kelloway, J. S., Wyatt, R. A., & Adlis, S. A. (1994). Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Archieves of Intern Medicine, 154, 1349–1352.CrossRef Kelloway, J. S., Wyatt, R. A., & Adlis, S. A. (1994). Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Archieves of Intern Medicine, 154, 1349–1352.CrossRef
go back to reference Kubacka, R. T., & Juhl, R. P. (1985). Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. American Journal of Hospital Pharmacy, 42, 2499–2501.PubMed Kubacka, R. T., & Juhl, R. P. (1985). Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. American Journal of Hospital Pharmacy, 42, 2499–2501.PubMed
go back to reference Lee, J. Y., Kusek, J. W., Greene, P. G., Bernhard, S., Norris, K., Smith, D., Wilkening, B., & Wright, J. T. Jr. (1996). Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. American Journal of Hypertension, 9, 719–725.PubMedCrossRef Lee, J. Y., Kusek, J. W., Greene, P. G., Bernhard, S., Norris, K., Smith, D., Wilkening, B., & Wright, J. T. Jr. (1996). Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. American Journal of Hypertension, 9, 719–725.PubMedCrossRef
go back to reference Lee, M., Kemp, J. A., Canning, A., Egan, C., Tataronis, G., & Farraye, F. A. (1999). A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Archives of Internal Medicine, 159, 2312–2316.PubMedCrossRef Lee, M., Kemp, J. A., Canning, A., Egan, C., Tataronis, G., & Farraye, F. A. (1999). A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Archives of Internal Medicine, 159, 2312–2316.PubMedCrossRef
go back to reference Mai, L., & Eng, J. (2007). Community-based elder care: A model for working with the marginally housed elderly. Care Management Journals, 8(2), 96–99.PubMedCrossRef Mai, L., & Eng, J. (2007). Community-based elder care: A model for working with the marginally housed elderly. Care Management Journals, 8(2), 96–99.PubMedCrossRef
go back to reference Mann, E., Eliasson, O., Patel, K., & ZuWallack, R. L. (1992). A comparison of the effects on bid and qid dosing on compliance with inhaled flunisolide. Chest, 101, 496–499.PubMedCrossRef Mann, E., Eliasson, O., Patel, K., & ZuWallack, R. L. (1992). A comparison of the effects on bid and qid dosing on compliance with inhaled flunisolide. Chest, 101, 496–499.PubMedCrossRef
go back to reference Martin, S., Wolters, P. L., Calabrese, S. K., Toledo-Tamula, M. A., Wood, L. V., Roby, G., et al. (2007). The Antiretroviral Regimen Complexity Index: A novel method of quantifying regimen complexity. Journal of Acquired Immune Deficiency Syndrome, 45, 1–10.CrossRef Martin, S., Wolters, P. L., Calabrese, S. K., Toledo-Tamula, M. A., Wood, L. V., Roby, G., et al. (2007). The Antiretroviral Regimen Complexity Index: A novel method of quantifying regimen complexity. Journal of Acquired Immune Deficiency Syndrome, 45, 1–10.CrossRef
go back to reference Masand, P. S. (2003). Tolerability and adherence issues in antidepressant therapy. Clinical Therapy, 25, 2289–2304.CrossRef Masand, P. S. (2003). Tolerability and adherence issues in antidepressant therapy. Clinical Therapy, 25, 2289–2304.CrossRef
go back to reference McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of the American Medical Association, 288, 2868–2879.PubMedCrossRef McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of the American Medical Association, 288, 2868–2879.PubMedCrossRef
go back to reference McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: The value of electronic monitoring. AIDS, 17, 1763–1767.PubMedCrossRef McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: The value of electronic monitoring. AIDS, 17, 1763–1767.PubMedCrossRef
go back to reference Misra, A., & Ganda, O. P. (2007). Migration and its impact on adiposity and type 2 diabetes. Nutrition (Burbank, Los Angeles County, Calif.), 23(9), 696–708. Misra, A., & Ganda, O. P. (2007). Migration and its impact on adiposity and type 2 diabetes. Nutrition (Burbank, Los Angeles County, Calif.), 23(9), 696–708.
go back to reference Molassiotis, A., Lopez-Nahas, V., Chung, W. Y., & Lam, S. W. (2003). A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care, 15, 125–135.PubMedCrossRef Molassiotis, A., Lopez-Nahas, V., Chung, W. Y., & Lam, S. W. (2003). A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care, 15, 125–135.PubMedCrossRef
go back to reference Morley, J. S., Bridson, J., Nash, T. P., Miles, J. B., White, S., & Makin, M. K. (2003). Low-dose methadone has an analgesic effect in neuropathic pain: A double-blind randomized controlled crossover trial. Palliative Medicine, 17, 576–587.PubMedCrossRef Morley, J. S., Bridson, J., Nash, T. P., Miles, J. B., White, S., & Makin, M. K. (2003). Low-dose methadone has an analgesic effect in neuropathic pain: A double-blind randomized controlled crossover trial. Palliative Medicine, 17, 576–587.PubMedCrossRef
go back to reference Murphy, D. A., Roberts, K. J., Martin, D. J., Marelich, W., & Hoffman, D. (2000). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs, 14, 47–58.PubMedCrossRef Murphy, D. A., Roberts, K. J., Martin, D. J., Marelich, W., & Hoffman, D. (2000). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs, 14, 47–58.PubMedCrossRef
go back to reference O’Shea, S. D., Taylor, N. F., & Paratz, J. D. (2007). But watch out for the weather: Factors affecting adherence to progressive resistance exercise for persons with COPD. Journal of Cardiopulmonary Rehabilitation and Prevention, 27(3), 166–174; quiz 175–176.PubMed O’Shea, S. D., Taylor, N. F., & Paratz, J. D. (2007). But watch out for the weather: Factors affecting adherence to progressive resistance exercise for persons with COPD. Journal of Cardiopulmonary Rehabilitation and Prevention, 27(3), 166–174; quiz 175–176.PubMed
go back to reference Paes, A. H., Bakker, A., & Soe-Agnie, C. J. (1997). Impact of dosage frequency on patient compliance. Diabetes Care, 20, 1512–1517.PubMedCrossRef Paes, A. H., Bakker, A., & Soe-Agnie, C. J. (1997). Impact of dosage frequency on patient compliance. Diabetes Care, 20, 1512–1517.PubMedCrossRef
go back to reference Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed
go back to reference Peterson, A. M., Takiya, L., & Finley, R. (2003). Meta-analysis of trials of interventions to improve medication adherence. American Journal of Health System Pharmacy, 60, 657–665.PubMed Peterson, A. M., Takiya, L., & Finley, R. (2003). Meta-analysis of trials of interventions to improve medication adherence. American Journal of Health System Pharmacy, 60, 657–665.PubMed
go back to reference Pinter, B. (2002). Continuation and compliance of contraceptive use. European Journal of Contraception and Reproductive Health Care, 7, 178–183.PubMedCrossRef Pinter, B. (2002). Continuation and compliance of contraceptive use. European Journal of Contraception and Reproductive Health Care, 7, 178–183.PubMedCrossRef
go back to reference Portsmouth, S. D., Osorio, J., McCormick, K., Gazzard, B. G., & Moyle, G. J. (2005). Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: A 24-week randomized trial of treatment simplification using prolonged-release capsules. HIV Medicine, 6, 185–190.PubMedCrossRef Portsmouth, S. D., Osorio, J., McCormick, K., Gazzard, B. G., & Moyle, G. J. (2005). Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: A 24-week randomized trial of treatment simplification using prolonged-release capsules. HIV Medicine, 6, 185–190.PubMedCrossRef
go back to reference Purucker, M. E., Rosebraugh, C. J., Zhou, F., & Meyer, R. J. (2003). Inhaled fluticasone propionate by diskus in the treatment of asthma: A comparison of the efficacy of the same nominal dose given either once or twice a day. Chest, 124, 1584–1593.PubMedCrossRef Purucker, M. E., Rosebraugh, C. J., Zhou, F., & Meyer, R. J. (2003). Inhaled fluticasone propionate by diskus in the treatment of asthma: A comparison of the efficacy of the same nominal dose given either once or twice a day. Chest, 124, 1584–1593.PubMedCrossRef
go back to reference Richter, A., Anton, S. E., Koch, P., & Dennett, S. L. (2003). The impact of reducing dose frequency on health outcomes. Clinical Therapy, 25, 2307–2335.CrossRef Richter, A., Anton, S. E., Koch, P., & Dennett, S. L. (2003). The impact of reducing dose frequency on health outcomes. Clinical Therapy, 25, 2307–2335.CrossRef
go back to reference Rueda, S., Park-Wyllie, L. Y., Bayoumi, A. M., Tynan, A. M., Antoniou, T. A., Rourke, S. B., & Glazier, R. H. (2006). Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Systematic Review, 3, CD001442. Rueda, S., Park-Wyllie, L. Y., Bayoumi, A. M., Tynan, A. M., Antoniou, T. A., Rourke, S. B., & Glazier, R. H. (2006). Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Systematic Review, 3, CD001442.
go back to reference Sankar, A. P., Nevedal, D. C., Neufeld, S., & Luborsky, M. R. (2007). What is a missed dose? Implications for construct validity and patient adherence. AIDS Care, 19(6), 775–780.PubMedCrossRef Sankar, A. P., Nevedal, D. C., Neufeld, S., & Luborsky, M. R. (2007). What is a missed dose? Implications for construct validity and patient adherence. AIDS Care, 19(6), 775–780.PubMedCrossRef
go back to reference Shoptaw, S., Reback, C. J., & Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases, 21, 91–105.PubMedCrossRef Shoptaw, S., Reback, C. J., & Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases, 21, 91–105.PubMedCrossRef
go back to reference Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. Journal of Acquired Immune Deficiency Syndrome, 43, S1, S23–S35. Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. Journal of Acquired Immune Deficiency Syndrome, 43, S1, S23–S35.
go back to reference Stone, V. E., Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., & Smith, D. K. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndromes, 28, 124–131. Stone, V. E., Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., & Smith, D. K. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndromes, 28, 124–131.
go back to reference Trotta, M. P., Ammassari, A., Melzi, S., Zaccarelli, M., Ladisa, N., Sighinolfi, L., Mura, M. S., d’Arminio Monforte, A., Antinori, A., & AdICoNA Study Group (2002). Treatment-related factors and highly active antiretroviral therapy adherence. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S128–131. Trotta, M. P., Ammassari, A., Melzi, S., Zaccarelli, M., Ladisa, N., Sighinolfi, L., Mura, M. S., d’Arminio Monforte, A., Antinori, A., & AdICoNA Study Group (2002). Treatment-related factors and highly active antiretroviral therapy adherence. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S128–131.
go back to reference Wilson, I. B., Tchetgen, E., & Spiegelman, D. (2001). Patterns of adherence with antiretroviral medications: An examination of between-medication differences. Journal of Acquired Immune Deficiency Syndromes, 28, 259–263.PubMed Wilson, I. B., Tchetgen, E., & Spiegelman, D. (2001). Patterns of adherence with antiretroviral medications: An examination of between-medication differences. Journal of Acquired Immune Deficiency Syndromes, 28, 259–263.PubMed
go back to reference Witteveen, E., & van Ameijden, E. J. (2002). Drug users and HIV-combination therapy (HAART): Factors which impede or facilitate adherence. Substance Use and Misuse, 37, 1905–1925.PubMedCrossRef Witteveen, E., & van Ameijden, E. J. (2002). Drug users and HIV-combination therapy (HAART): Factors which impede or facilitate adherence. Substance Use and Misuse, 37, 1905–1925.PubMedCrossRef
go back to reference Wohl, D. A., Stephenson, B. L., Golin, C. E., Kiziah, C. N., Rosen, D., Ngo B., Liu, H., & Kaplan, A. H. (2003). Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infectious Diseases, 36, 1572–1576.PubMedCrossRef Wohl, D. A., Stephenson, B. L., Golin, C. E., Kiziah, C. N., Rosen, D., Ngo B., Liu, H., & Kaplan, A. H. (2003). Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infectious Diseases, 36, 1572–1576.PubMedCrossRef
go back to reference World Health Organization (WHO). (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: WHO. World Health Organization (WHO). (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: WHO.
go back to reference Yiannakopoulou, E. C., Papadopulos, J. S., Cokkinos, D. V., & Mountokalakis, T. D. (2005). Adherence to antihypertensive treatment: A critical factor for blood pressure control. European Journal of Cardiovascular Prevention and Rehabilitation, 12, 243–249.PubMedCrossRef Yiannakopoulou, E. C., Papadopulos, J. S., Cokkinos, D. V., & Mountokalakis, T. D. (2005). Adherence to antihypertensive treatment: A critical factor for blood pressure control. European Journal of Cardiovascular Prevention and Rehabilitation, 12, 243–249.PubMedCrossRef
Metagegevens
Titel
The impact of medication regimen factors on adherence to chronic treatment: a review of literature
Auteurs
Karen S. Ingersoll
Jessye Cohen
Publicatiedatum
01-06-2008
Uitgeverij
Springer US
Gepubliceerd in
Journal of Behavioral Medicine / Uitgave 3/2008
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-007-9147-y

Andere artikelen Uitgave 3/2008

Journal of Behavioral Medicine 3/2008 Naar de uitgave